Nanobiotix annual current ratio
2019
2020
2021
2022
2023
2024
2025
Nanobiotix Current Ratio Growth & History (NANO)
Nanobiotix's current ratio was 1.09 for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.09 | 0.05 | +4.62% |
| 2024 | 2024-12-31 | 1.04 | −0.71 | −40.44% |
| 2023 | 2023-12-31 | 1.75 | 0.37 | +26.89% |
| 2022 | 2022-12-31 | 1.38 | −1.15 | −45.36% |
| 2021 | 2021-12-31 | 2.53 | −4.05 | −61.60% |
| 2020 | 2020-12-31 | 6.58 | 3.36 | +104.59% |
| 2019 | 2019-12-31 | 3.22 | — | — |
Nanobiotix quarterly current ratio
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 1.09 | 0.05 | +4.62% |
| Q2 2025 | 2025-06-30 | 0.63 | −0.79 | −55.55% |
| Q4 2024 | 2024-12-31 | 1.04 | −0.71 | −40.44% |
| Q2 2024 | 2024-06-30 | 1.42 | 0.75 | +111.05% |
| Q4 2023 | 2023-12-31 | 1.75 | 0.37 | +26.89% |
| Q2 2023 | 2023-06-30 | 0.67 | −1.04 | −60.58% |
| Q4 2022 | 2022-12-31 | 1.38 | −1.15 | −45.36% |
| Q2 2022 | 2022-06-30 | 1.71 | −1.34 | −43.83% |
| Q4 2021 | 2021-12-31 | 2.53 | −4.05 | −61.60% |
| Q2 2021 | 2021-06-30 | 3.05 | — | — |
| Q4 2020 | 2020-12-31 | 6.58 | 3.36 | +104.59% |
| Q4 2019 | 2019-12-31 | 3.22 | — | — |
Nanobiotix current ratio trends
Over the last five fiscal years, Nanobiotix's current ratio decreased from 6.58 to 1.09, a change of −5.49. The latest reported quarter, Q4 2025, shows 1.09.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗